Find

Search Newsmax Health Search Newsmax Search Web
Newsletters Video Shop Contact Us Archives
 
Newsmax Newsmax Moneynews Newsmax.TV
 
 
Health Stories  

Drugs Slash HIV Risk by 92 Percent

Friday, May 28, 2010 8:18 AM

Print this Page  

Forward Page  Forward Page

Email Us  Email Us

People with HIV reduced the risk of passing on the AIDS virus by an astonishing 92 percent while they were taking antiretroviral drugs, according to a trial reported on Thursday.

The research provides the strongest evidence to date that drugs which treat the human immunodeficiency virus could also be incorporated into strategies for fighting HIV's spread.

In a paper published by the British journal The Lancet, doctors recruited 3,381 heterosexual couples in seven African countries.

Each couple was "serodiscordant," meaning that one of the pair was infected with HIV while the other was uninfected.

Antiretroviral drugs were given to 349 individuals after their immune system, as measured by the numbers of CD4 cells, plunged below a given threshold. The other infected individuals received a dummy pill called a placebo.

The researchers took blood samples from the other partner every three months to see whether he or she had become infected. The trial was closely monitored by an ethics committee, and included a training course in safe sex as well as routine health checkups.

After 24 months, 103 partners who had been HIV-free at the start of the experiment had become infected with the virus by their partner.

But only one of these 103 transmissions was caused by a partner who was on antiretrovirals.

The results were confirmed by genetic fingerprinting of the virus, showing whether it had been passed on by an infected partner or by someone from outside the trial.

All in all, taking antiretroviral therapy (ART) reduced the risk of infecting someone else by 92 percent, a whopping fall that highlights the potential of these drugs as a weapon to prevent HIV, rather than just treat it, say the authors.

"Provision of ART to HIV-1 infected patients could be an effective strategy to achieve population-level reductions in HIV-1 transmission," says the paper.

HIV-1 is the most common strain of the AIDS virus.

ART cuts down the amount of virus in blood and body fluids and so reduces exposure to a non-infected person, experts believe.

There is a caveat, though, say the authors. Even though ART may lower the risk of infecting others, the danger is not eliminated, so safe-sex counseling is essential.

Copyright AFP

 

 

   
   
   
       Privacy Policy  |  Terms & conditions  |  Contact Us

PLEASE NOTE: All information presented in Newsmaxhealth.com and Newsmax.com is for informational purposes only. It is not specific medical advice for any individual. All answers to reader questions are provided for informational purposes only. All information presented on our websites should not be construed as medical consultation or instruction. You should take no action solely on the basis of this publication’s contents. Readers are advised to consult a health professional about any issue regarding their health and well-being. While the information found on our websites is believed to be sensible and accurate based on the author’s best judgment, readers who fail to seek counsel from appropriate health professionals assume risk of any potential ill effects. The opinions expressed in Newsmaxhealth.com and Newsmax.com do not necessarily reflect those of Newsmax Media. Please note that this advice is generic and not specific to any individual. You should consult with your doctor before undertaking any medical or nutritional course of action